Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline added to standard treatment for hospitalized adults with COVID-19
IRCT20220110053681N1Phase 3Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sertraline in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Sabzevar University of Medical Sciences. Primary endpoint: Effect of sertraline on prognosis of hospitalized patients with COVID-19. Started Apr 2022; status: completed.
02
Drugs
sertraline
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20220110053681N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220110053681N1.